Result Summary for 208108-083
| Protocol ID: | 208108-083 |
| Clinical Study ID: | 208108-083 (Hib-083) |
| Official Title: | A phase IV, open, multicentric, post-marketing surveillance study to monitor the safety and reactogenicity of GlaxoSmithKline Biologicals’ Haemophilus influenzae type b vaccine (Hiberix™) in Korean subjects administered according to the Prescribing Information. |
| Phase: | Phase 4 |
| Study Indications or Diseases: |
|
| Generic Name: | Haemophilus influenzae Type b Vaccine |
| Trade/Product Name: | Hiberix |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
